Measles, Vaccines, Antibodies and Big Pharma Money

Download Measles, Vaccines, Antibodies and Big Pharma Money

Post on 16-Jul-2015

198 views

Category:

Health & Medicine

0 download

Embed Size (px)

TRANSCRIPT

<ul><li><p>Vaccination is NOT Immunization Vran.orgVaclib.orgNVIC.orggreenmedinfo.comthinktwice.orgSanevax.orgvaccinationcouncil.orgvaccinetruth.orgdrsuzanne.netdrtenpenny.com"The great enemy of the truth is very often not the lie, deliberate, contrived and dishonest, but the myth, persistent, persuasive and unrealistic</p></li><li><p>Myths and DogmaVaccines are Safe and effective</p><p>Vaccine preventable diseases</p><p>Get vaccinated to protect those that cant have a vaccine</p><p>Herd immunity</p><p>Vaccines are the best way to protect your family</p></li><li><p>Individuals harmed by properly manufactured vaccines had few options for compensation before an court case in the 1950s</p><p>In 1955 about 200 people were paralyzed and ten died after contracting polio from the Salk polio vaccinecertain lots of which contained virus that had not been inactivated in spite of manufacturers adherence to federal government standards.DPT LawsuitsThrough the 1970s and 1980sthe number of lawsuits brought against vaccine manufacturers increased dramatically, and manufacturers made large payouts to individuals and families claiming vaccine injury, particularly from the combined diphtheria-pertussis-tetanus (DPT) immunization.mounting legal fees, and large jury rewards, many pharmaceutical companies left the vaccine businessby the end of 1984, only one U.S. company still manufactured the DPT vaccineother vaccines were losing manufacturers as well.</p></li><li><p>Under the NVICP, those claiming a vaccine injury from a covered vaccine cannot sue a vaccine manufacturer without first filing a claim with the U.S. Court of Federal Claims</p><p>The claim filer is reimbursed according to a formula, provided that all the medical records meet NCVIA standards and that review by the U.S. Department of Justice determines that all legal standards have been met.</p><p> If a claim is denied, or if the claim is approved and the claimant rejects the compensation, only then may the claimant file a civil lawsuit.</p><p>The National Childhood Vaccine Injury Act Reporting and Compensation Tables (VIT) list each covered vaccine, its associated adverse events, and the allowable interval from vaccination to onset of event. </p><p>intussusseption within 30 days of receipt of oral, rhesus-based rotavirus vaccinebrachial neuritis within 0-28 days of receipt of tetanus toxoidanaphylaxis within 0-4 hours of receipt of a variety of vaccines, etc</p></li><li><p>it is estimated that only 1-10% of events are reported JAMA 1993</p><p>Between mid-1999 &amp; Jan. 4th 2004 there were 128,035 adverse reactions reported to VAERS this may represent between 1.28 million to 12.8 million of the actual vaccine associated adverse reactionsVAERs Vaccine Adverse Events Reporting System</p></li><li><p>U.S. Department of Health and Human Services published Statistics Reports period ending September 3, 2013 1989 to 20133,387 compensable claimsor money9,651 claims that were dismissed The U.S. Court of Federal Claims (aka the vaccine court) $2,569,336,538.59 for compensable claims $104,202,681.85 for attorneys feesattorneys fees for dismissed claims totaling $56,375,431.34$15,190,454.29 for interim attorneys fees the vaccines causing the most damage were: DPT 3,284; Influenza (Trivalent) 1,108; MMR 860; Hepatitis B 591; DtaP 353; OPV (Oral Polio) 280 The vaccine attributed to causing the most deaths was DTP with 696 deaths. 32 vaccines listed, very fewonly 5had no deaths attributed.</p></li><li><p>Federal Register, volume 49, Number 107 Friday 1 June, 1984, Rules and Regulations page 23007 which said: Any possible doubts, whether or not well founded, about the safety of the (polio) vaccine, cannot be allowed to exist in view of the need to assure that the vaccine will continue to be used to the maximum extent. </p></li><li><p>One strain came from lung cells taken from a female fetus of 3-months gestation, One strain from a male fetus at 14-weeks. One strain was used to make the rubella vaccine </p><p>the fetuses were intentionally aborted, but were not aborted for the purpose of harvesting the cells. these cultures have been used to prepare hundreds of millions of doses of vaccines for rubella, hepatitis A, varicella, rabies, chicken pox vaccine </p><p>The defense is that human cells are the best source for vaccines because cells taken from animals can carry animal viruses that would obviously be very harmful in any vaccine.</p></li><li><p>An additional increased spike in incidence of autism occurred in 1995 when the chicken pox vaccine was grown in human fetal tissue.Human. Fetal. Tissue.</p><p>The National Network for Immunization Information reports that two different strains of human cell cultures made from fetuses have been used extensively in vaccine production for DECADES.</p><p> Theoretical aspects of autism: Causes-A review Helen V. Ratajczak, Journal of Immunotoxicology, Vol. 8, No. 1, 2/9/11, informahealthcare.com Vaccines and autism: a new scientific review Sharyl Attkisson, CBS News, 3/31/11, cbsnews.com Human Fetal Links with Some Vaccines National Network for Immunization Information, 6/3/08, immunizationinfo.org</p></li><li><p>THE FUTURE OF MEASLES IN HIGHLY IMMUNIZED POPULATIONS A MODELING APPROACH</p><p>American Journal of Epidemiology1984 Volume 120, Issue 1 Pp. 39-48. AbstractLittle is known about how an intensive measles elimination program changes the overall immune status of the population. A computer model was created to study the effect of the measles elimination program in the United States on the number of susceptibles in the population. </p><p>the prevaccine era, approximately 10.6% of the population was susceptible to measles With the institution of the measles immunization program, the proportion of susceptibles in the population fell to 3.1% from 1978 through 1981 then began to rise by approximately 0.1% per year to reach about 10.9% in the year 2050. </p></li><li><p>THE FUTURE OF MEASLES IN HIGHLY IMMUNIZED POPULATIONS A MODELING APPROACHAmerican Journal of EpidemiologyVolume 120, Issue 1 Pp. 39-48. The susceptibles at this time were distributed evenly throughout all age groups. The model did not consider the potential effect of waning immunity. The results of this study suggest that measles elimination in the United States has been achieved by an effective immunization program aimed at young susceptibles combined with a highly, naturally immunized adult population. However, despite short-term success in eliminating the disease, long-range projections demonstrate that the proportion of susceptibles in the year 2050 may be greater than in the prevaccine era. Present vaccine technology and public health policy must be altered to deal with this eventuality. </p></li><li><p>Increased risk of non-influenza respiratory virus infections associated with receipt of inactivated influenza vaccineClin Infect Dis. 2012 </p><p>AbstractWe randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo. </p><p>Over the following 9 months, TIV recipients had increased risk of virologically-confirmed non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8). </p><p>Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses. </p></li><li><p>Implications of Vaccination and Waning Immunity, Proceedings of the Royal Society B, vol. 276, 2009J. M. Heffernan and M. J. Keeling When immunity wanes, vaccination has a far more limited impact on the average number of cases. While this observation has clear public-health implications, the dynamic consequences of the interaction between vaccination, waning immunity and boosting are far more striking.</p><p> For high levels of vaccination (greater than 80%) and moderate levels of waning immunity (greater than 30 years), large-scale epidemic cycles can be induced. </p></li><li><p>While the role of antibodies in preventing virus infection and reinfection is unquestionable, their contribution to the resolution of viral disease is much more controversial. </p><p>When humoral deficiencies, in particular Bruton's X-linked agammaglobulinemia (XLA) (8), were initially described, it was observed that bacterial infections rather than viral infections represented the main cause of morbidity and early mortality.</p><p> On this basis it was proposed that humoral deficiencies could be seen as experiments of nature, demonstrating that antibodies play little or no role in controlling viral infections while they are crucial in the resolution of bacterial infections (discussed in reference 24). Such a view has acquired dogma status over the years and is commonly found in immunology textbooks and other scientific publications.Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene KnockoutsJ Virol. 2000 Nov; 74(21): 98139817. </p></li><li><p>While the role of antibodies in preventing virus infection and reinfection is unquestionable, their contribution to the resolution of viral disease is much more controversial. </p><p>When humoral deficiencies, in particular Bruton's X-linked agammaglobulinemia (XLA) (8), were initially described, it was observed that bacterial infections rather than viral infections represented the main cause of morbidity and early mortality.</p><p> On this basis it was proposed that humoral deficiencies could be seen as experiments of nature, demonstrating that antibodies play little or no role in controlling viral infections while they are crucial in the resolution of bacterial infections (discussed in reference 24). Such a view has acquired dogma status over the years and is commonly found in immunology textbooks and other scientific publications.Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene KnockoutsJ Virol. 2000 Nov; 74(21): 98139817. </p><p>demonstrating that antibodies play little or no role in controlling viral infections while they are crucial in the resolution of bacterial infections . Such a view has acquired dogma status over the years and is commonly found in immunology textbooks and other scientific publications</p></li><li><p>One of the most disconcerting discoveries in clinical medicine was the finding that children with congenital agamma-globulinaemia, who could make no antibody and had only insignificant traces of immunoglobulin in circulation,</p><p> contracted measles in normal fashion, showed the usual sequence of symptoms and signs, and were subsequently immune. No measles antibody was detectable in their serum Measles as an Index of Immunological Function, The Lancet, September 14, 1968, p. 611. </p></li><li><p>Measles Vaccine Putting mothers and Children at Risk</p></li><li><p>Herd Immunity Not Based in factThen when that didnt work.</p></li><li><p>www.medalerts.org</p></li><li><p>American Babies:1 vaccine at birth8 vaccines at 2 months9 Vaccines at 6 months12 vaccines at 12 18 months</p><p>Total 38 vaccines by 18 months CDC 2011</p></li><li><p>CDC 2011 Recommendation</p><p>USA Babies to 18 months old:</p><p>4 doses of Hep B3 doses of rotavirus4 doses of DTaP9 (diphtheria, tetanus, pertussis)4 doses of Hib (haemophilus influenza B)4 doses of pneumococcal vaccine (prevnar 13)3 doses of polio vaccine2 doses of Flu vaccine1 MMR (measels, mumps, rubella)1 chicken pox vaccine22 Medical Studies That Show Vaccines Can Cause Autism</p></li><li><p>a macaque monkey (primates) study of the very same vaccines given to children during 1994-1999, Laura Hewitson, PhD</p><p>Vaccine-exposed and saline-injected control infants [monkeys] underwent MRI and PET imaging at approximately 4 and 6 months of age, representing two specific timeframes within the vaccination schedule. These results suggest that maturational changes in amygdala volume and the binding capacity of [11C]DPN in the amygdala was significantly altered in infant macaques receiving the vaccine schedule. many significant differences in the GI tissue gene expression profiles between vaccinated and unvaccinated animals. </p><p>biological changes and altered behaviors did occur in vaccinated monkeys, which resembled ASD diagnosed children. no such symptoms showing or present in unvaccinated monkeys.</p><p>Research Paper :Neurobiological Experimentals in 2010 and titled Influence of pediatric vaccines on amydgala growth and opioid ligand binding in rhesus macaque infants: A pilot study. </p></li><li><p>CDC Whistleblower Announces That the MMR Vaccine Causes Autism</p><p>CDC whistleblower, William Thompson, Thompson admitted that the CDC had deliberately withheld crucial evidence proving that the MMR (measles, mumps and rubella) vaccine caused autism.</p><p>research carried out by the CDC in Atlanta, Georgia, revealed that when African-American boys under the age of 36 months were given the MMR vaccine, the rate of autism in this group rose by 340 percent.</p><p>In a desperate bid to cover up this tragedy, the CDC decided to fix the data and eliminated all African-American boys without a Georgia birth certificate.340% increase in Autism covered up in 2004</p></li><li><p> 50% of U.S. Children Have Chronic Disease/Disorders, 21% DevelopmentallyDisabledCurrent rate of Autism 1 in 33 boys</p><p>2007 Academic Pediatrics, an estimated 43% to 54.1% of US children (32 million) have a chronic health conditions .</p><p>2011 issue of Pediatrics Between 1997 and 2008, the number of school-age children diagnosed with autism, ADHD, or another developmental disability. </p><p>2011 Archives of General Psychiatry and it found that the U.S. has the highest in the world lifetime rate of bipolar disorder at 4.4%</p><p>2013 autism, ADHD, or another developmental disability=amount to 21% </p><p>By 2016 60%-70% of American children, chronically ill, obesity, infertility.</p></li><li><p>J Autoimmun. 2011 Feb;The role of various environmental factors in the pathogenesis of immune mediated diseases is well established. </p><p>Of which, factors entailing an immune adjuvant activity such as infectious agents, silicone, aluminium salts and others were associated with defined and non-defined immune mediated diseases both in animal models and in humans. </p><p>SiliconosisGulf war syndrome (GWS)macrophagic myofasciitis syndrome (MMF)post-vaccination phenomena'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants.</p></li><li><p>Despite a lack of good-quality evidence we do not recommend that any further research on this topic is undertakenLancet Infect Dis. 2004 Feb;4(2):84-90.Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence</p><p>Assessment of the safety of aluminium in vaccines is important because replacement of aluminium compounds in currently licensed vaccines would necessitate the introduction of a completely new compound that would have to be investigated before licensing. No obvious candidates to replace aluminium are available, so withdrawal for safety reasons would severely affect the immunogenicity and protective effect of some currently licensed vaccines and threaten immunization programs worldwide.</p></li><li><p>Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.</p><p>Despite over 50 years of population-wide vaccination, whooping cough incidence is on the rise.</p><p>We show that aP vaccination helped clear B. pertussis but resulted in an approximately 40-fold increase in B. parapertussis lung colony-forming units (CFUs). </p><p>vaccine-mediated facilitation of B. parapertussis </p><p>Further, we show that...</p></li></ul>